David Nichols

https://www.heffter.org/

David Earl Nichols is an American pharmacologist and medicinal chemist. David is the founding president of the Heffter Research Institute, has published hundreds of research papers, and is considered to be one of the world's top experts on psychedelics.

4-AcO-DMT Is the Most Accessible (and Mysterious) Drug on the Market Right Now

If you live in a major North American city, you may have noticed a sudden influx of psychedelics-laced gummies, chocolates, and various other products in...

The Heirs to a Vault of Novel Psychedelics Take a Trip Into the Unknown

In April 1960, a Dow Chemicals biochemist named Alexander Shulgin consumed 400mg of a compound called mescaline, and had his first psychedelic experience. He saw...

What is Psilacetin?

You may have never heard of psilacetin. In fact, when you first saw it, it may have confused you. “Is this a misspelling of psilocybin?...

What’s the Future of Eleusis Therapeutics After Acquisition by Beckley Psytech?

Beckley Psytech, the private UK-based company led by longtime psychonaut Lady Amanda Feilding and her son, Cosmo Feilding Mellen, has agreed to acquire Eleusis Therapeutics,...

Eleusis Holdings Merges with Beckley Psytech

Eleusis Holdings, a venture capital-backed startup company that funded pioneering research into the anti-inflammatory properties of psychedelics, has agreed to merge with Beckley Psytech, the...

Heffter Research Institute

Founder

CATALYST Summit 2021: Psychedelic Medicine Global Conference

May 07, 2021

Psychedelics for the Treatment of Depression and Psychiatric Disorders

May 25, 2021

Last updated: Apr 16, 2021

Request Deletion